Table 1.
hPLAP activities in noninactivated (NI) and heat-inactivated (I) pregnant serum measured by ICA-PLAP and ICA-PEP.
Serum sample | Patient age (years) | Time of pregnancy (weeks) | ICA-PLAP hPLAP (U/L) | ICA-PEP hPLAP (U/L) | ||
NI | I | NI | I | |||
1 | 35 | 12 | 0.1 | 0.1 | 0.1 | 0.2 |
2 | 33 | 18 | 1.58 | 1.7 | 2 | 2.5 |
3 | 28 | 27 | 33 | 35.5 | 36 | 35.5 |
4 | 26 | 32 | 31 | 31 | 34 | 32 |
5 | 24 | 33 | 51.5 | 49 | 53 | 52 |
5 | 32 | 35 | 42 | 44 | 40.2 | 43 |
6 | 27 | 37 | 43 | 42 | 41 | 44 |